Dirk Rj Kuypers
0000-0001-5546-9680
445 papers found
Refreshing results…
Polyomavirus BK Genome Comparison Shows High Genetic Diversity in Kidney Transplant Recipients Three Months after Transplantation
Hyperhomocysteinemia: a trigger for complement-mediated TMA?
Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome
Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation
Technology Experience of Solid Organ Transplant Patients and Their Overall Willingness to Use Interactive Health Technology
The Transform Study: Lower Viral Infections With Everolimus and Reduced Calcineurin Inhibitor Versus Mycophenolate and Standard Calcineurin Inhibitor in De Novo Kidney Transplant Patients at Month 12
Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies
Pretransplant 4β‐hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation
Clinical Trials for Immunosuppression in Transplantation
Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal Recipients
Tubulointerstitial expression and urinary excretion of connective tissue growth factor 3 months after renal transplantation predict interstitial fibrosis and tubular atrophy at 5 years in a retrospective cohort analysis
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients
Kidney Fibrosis
Drug–drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients
A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study
Response to: ‘Bodyweight‐adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance’
Advancing Transplantation
Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients:
In Vitro Tacrolimus Exposure in Human Proximal Tubule Cells Results in Differentially Increased CTGF Expression in Relation to the Pharmacogenetic Background for Cyp3a5 and Abcb1
Missing publications? Search for publications with a matching author name.